Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07549919 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants
A Phase 1 study, sponsored by AnnJi Pharmaceutical Co..
- Recruiting
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT07549919 is a Phase 1 study that is actively recruiting participants, run by AnnJi Pharmaceutical Co.. The registered enrollment target is 26 participants.
The verdict
NCT07549919, a Phase 1 study, is actively recruiting participants, sponsored by AnnJi Pharmaceutical Co..
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This is a Phase 1, randomized, single-dose, open-label, two-way crossover study to evaluate the effect of food on AJ201, and to evaluate the safety, tolerability, and pharmacokinetics of AJ201 in Japanese and White healthy male participants.
Interventions
- DRUG AJ201
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2026-04-09 |
| Est. Completion | 2026-04-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07549919
The ClinicalTrials.gov registry entry for NCT07549919 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AnnJi Pharmaceutical Co., which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AJ201 is the first listed.
NCT07549919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07549919 about?
NCT07549919 is a clinical study titled "A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants". This is a Phase 1, randomized, single-dose, open-label, two-way crossover study to evaluate the effect of food on AJ201, and to evaluate the safety, tolerability, and pharmacokinetics of AJ201 in Japanese and White healthy male participants.
What is the current status of trial NCT07549919?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2026-04-09. Estimated completion is 2026-04-27.
What interventions are being tested in trial NCT07549919?
The interventions under investigation include: AJ201 (DRUG).
Who is sponsoring clinical trial NCT07549919?
This trial is sponsored by AnnJi Pharmaceutical Co., which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.